Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-08 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-08 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |